Nov 28 2016

DEA outlaws synthetic opiod U-47700

On November 14, the U.S. Drug Enforcement Agency (DEA) reclassified the synthetic opioid U-47700 as a Class 1 drug.  Originally developed by Upjohn Pharmaceuticals in the 1970s, U-47700 is a synthetic opioid that is 7-10 times more potent than heroin, and is known as “pink” or “pinky” on the street.  At least 50 deaths in the United States have been linked to U-47700.  As the demand for opioids increases in the United States and abroad, chemists have taken to the internet and found this chemical formula and a recipe for its manufacturing.  Although the drug is not currently being used for medical purposes in the United States, individuals could purchase it legally online from suppliers in China and eastern Europe.    U-47700 can cause euphoria, sedation, constipation and respiratory depression even at low doses. At higher doses the drug will cause respiratory arrest.  Unfortunately, reversal agents like Naloxone have very little effect against this drug.

Steve Simmons | News and Articles

Leave a Reply

Your email address will not be published. Required fields are marked *